8. Huntington disease
197 clinical trials,   171 drugs   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways

Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-002088-98-PT
(EUCTR)
07/06/200616/03/2006Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseFull title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease HUNTINGTON’S DISEASE
MedDRA version: 8.0;Level: LLT;Classification code 10010331
Product Name: Ethyl-EPA
Product Code: LAX-101
INN or Proposed INN: Ethyl Icosapent
Other descriptive name: Ethyl-EPA
Amarin Neuroscience LtdNULLNot RecruitingFemale: yes
Male: yes
Portugal;Germany;United Kingdom;Spain;Italy
2EUCTR2005-002088-98-ES
(EUCTR)
29/12/200504/10/2005Full title of the trial : Estudio multicentrico, multinacional aleatorizado doble ciego con grupos paralelos y controlado con placebo de etil-EPA (etil eicosapentanoato) en pacientes con enfermedad de Huntington.Full title of the trial : Estudio multicentrico, multinacional aleatorizado doble ciego con grupos paralelos y controlado con placebo de etil-EPA (etil eicosapentanoato) en pacientes con enfermedad de Huntington. HUNTINGTON’S DISEASE
MedDRA version: 8.0;Level: llt;Classification code 10010331
Product Name: Ethyl-EPA
Product Code: LAX-101
Amarin Neuroscience LtdNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Portugal;Germany;United Kingdom;Spain;Italy
3EUCTR2005-002088-98-AT
(EUCTR)
01/12/200527/10/2005Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseFull title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease HUNTINGTON’S DISEASE
MedDRA version: 8.0;Level: LLT;Classification code 10010331
Product Name: Ethyl-EPA
Product Code: LAX-101
INN or Proposed INN: Ethyl-Icosapent
Amarin Neuroscience LtdNULLNot RecruitingFemale: yes
Male: yes
240Portugal;Spain;Austria;Germany;Italy;United Kingdom
4EUCTR2005-002088-98-GB
(EUCTR)
07/11/200518/08/2005Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseFull title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease HUNTINGTON’S DISEASE
MedDRA version: 8.0;Level: LLT;Classification code 10010331
Product Name: Ethyl-EPA
Product Code: LAX-101
Amarin Neuroscience LtdNULLNot RecruitingFemale: yes
Male: yes
Portugal;Germany;United Kingdom;Spain;Italy
5NCT00146211
(ClinicalTrials.gov)
September 20052/9/2005TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's DiseaseA Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's DiseaseHuntington DiseaseDrug: Ethyl-EPA (Miraxion™)Amarin Neuroscience LtdHuntington Study GroupCompleted35 YearsN/ABoth300Phase 3United States;Canada
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6EUCTR2005-002088-98-DE
(EUCTR)
28/11/2006Full title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s DiseaseFull title of the trial : A multicentre, multi-national, double-blind, randomised, parallel group placebo-controlled trial of ethyl-EPA (ethyl-icosapent) in patients with Huntington’s Disease HUNTINGTON’S DISEASE
MedDRA version: 8.0;Level: LLT;Classification code 10010331
Product Name: Ethyl-EPA
Product Code: LAX-101
INN or Proposed INN: Ethyl-Icosapent
Amarin Neuroscience LtdNULLNot RecruitingFemale: yes
Male: yes
240Portugal;United Kingdom;Germany;Spain;Italy